The Health and Human Services Department is considering cuts to HIV prevention funding, according to The Wall Street Journal.

Elisabeth Moss is leading a rebellion in the final season The Handmaid's Tale, which arrives on Hulu April 8. The streamer ...

BofA notes press reports that the Trump administration is allegedly considering cutting HIV prevention activities from the CDC budget and that ...

So, assuming 2% growth, Gilead is slightly undervalued. In fact, Gilead appears valued for 0% growth. Actually, this may be a ...

The U.S. Health and Human Services Department is weighing plans to drastically cut federal government funding for domestic ...

Elisabeth Moss leads the revolution to take down Gilead in the final season of "The Handmaid's Tale." The first three ...

In a report released today, Asthika Goonewardene from Truist Financial maintained a Hold rating on Gilead Sciences (GILD – Research Report).

Gilead is set to launch a Phase III trial of its once-yearly lenacapavir pre-exposure prophylaxis (PrEP) for human ...

The official trailer for The Handmaid's Tale's final season shows June (Elisabeth Moss) returning to Gilead amid a revolution ...

The final season of The Handmaid’s Tale will also find Samira Wiley’s Moira joining June and Luke in the resistance, while ...

After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price ...

Bay Area drug giant Gilead is plotting the trial of a groundbreaking, once-a-year HIV prevention drug lenacapavir.